- Q1 2024 DiaSorin SpA Earnings Call TranscriptMay 10, 2024$107.4Earnings
- Q3 2023 DiaSorin SpA Earnings Call TranscriptNov 03, 2023$87.45Earnings
- Half Year 2023 DiaSorin SpA Earnings Call TranscriptJul 27, 2023$96Earnings
- Q1 2023 DiaSorin SpA Earnings Call TranscriptMay 09, 2023$119.74Earnings
- Full Year 2022 DiaSorin SpA Earnings Call TranscriptMar 27, 2023$111.33Earnings
- Cytek Biosciences Inc To Acquire Flow Cytometry and Imaging Business From DiaSorin- M&A Call TranscriptFeb 13, 2023
- Q3 2022 DiaSorin SpA Earnings Call TranscriptOct 27, 2022$107Earnings
- Q2 2022 DiaSorin SpA Earnings Call TranscriptAug 03, 2022$144.11Earnings
- Q1 2022 DiaSorin SpA Earnings Call TranscriptMay 06, 2022$129Earnings
- Q4 2021 DiaSorin SpA Earnings Call TranscriptMar 16, 2022$130Earnings
- DiaSorin SpA Investor Day TranscriptDec 17, 2021
- Q3 2021 DiaSorin SpA Earnings Call TranscriptNov 11, 2021$220.95Earnings
- Q2 2021 DiaSorin SpA Earnings Call TranscriptJul 30, 2021$203.44 (+1.72%)Earnings
- Q1 2021 DiaSorin SpA Earnings Call TranscriptMay 14, 2021$173.25Earnings
- DiaSorin SpA to Acquire Luminex Corp Call TranscriptApr 12, 2021
- Q4 2020 DiaSorin SpA Earnings Call TranscriptMar 11, 2021$219Earnings
- Q3 2020 DiaSorin SpA Earnings Call TranscriptNov 11, 2020$183Earnings
- Q2 2020 DiaSorin SpA Earnings Call TranscriptJul 30, 2020$202.18Earnings
- Q1 2020 DiaSorin SpA Earnings Call TranscriptMay 13, 2020$169.66Earnings
- Q4 2019 DiaSorin SpA Earnings Call TranscriptMar 11, 2020$118.43 (-3.34%)Earnings
- Q3 2019 DiaSorin SpA Earnings Call TranscriptNov 06, 2019$114.75Earnings
- Q2 2019 DiaSorin SpA Earnings Call TranscriptJul 31, 2019$114.75Earnings
- DiaSorin SpA Investor Day TranscriptJun 11, 2019
- Q1 2019 DiaSorin SpA Earnings Call TranscriptMay 09, 2019$100.1Earnings
- Q4 2018 DiaSorin SpA Earnings Call TranscriptMar 14, 2019$95.67Earnings
Q3 2019 DiaSorin SpA Earnings Call Transcript
Good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining the DiaSorin 9 Months 2019 Results Conference Call. (Operator Instructions).
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.
Yes, thank you, operator. And good morning, good afternoon to everybody. Welcome to the quarter 3 conference call. As usual, I'm going to make some comments about the quarter and then I will turn the microphone to Mr. Pedron who is going to address the financials. As usual, I'm going to make my comments in constant exchange rate because of the -- we -- the company enjoys a favorable effect coming from the strength of the U.S. dollars.
So first I believe that this was a good quarter, both in terms of growth in the very relevant geographies where we play as well -- certainly as well as for the profitability. And I think we hit a record quarter in terms of cash flow generation.
If we look at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)